Lukas Biomedical Inc. (TPEX:6814)

Lukas Biomedical Revenue

Lukas Biomedical had revenue of 78.44M TWD in the half year ending June 30, 2026, a decrease of -19.49%. This brings the company's total for the last twelve months to 170.01M, down -5.72% year-over-year. In the year 2025, Lukas Biomedical had annual revenue of 179.49M, down -5.44%. That makes Lukas Biomedical the 39,841st largest company in the world by revenue and 2,063rd in Taiwan.

• Revenue (ttm): 170.01M
• Revenue Growth: -5.72%
• P/S Ratio: 4.56
• Revenue / Employee: n/a
• Employees: 87
• Market Cap: 778.86M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• e-Commerce Department 113.70M 63.3%
• Medical Management Operations 47.26M 26.3%
• Pharmaceutical Market Development Department 18.54M 10.3%

By Geography

Chart

• Taiwan 177.80M 99.1%
• Vietnam 1.48M 0.8%
• Thailand 111.00K 0.1%
• United State 109.00K 0.1%

Fiscal year ended Dec 31, 2025 See the full Lukas Biomedical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	179.49M	-10.34M	-5.44%
Dec 31, 2024	189.83M	-42.01M	-18.12%
Dec 31, 2023	231.83M	47.05M	25.46%
Dec 31, 2022	184.79M	27.17M	17.24%
Dec 31, 2021	157.62M	-23.79M	-13.12%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 29, 2026

Data Sources Report a data error